ArticlePloS one2018
Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.
Devki Nandan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticlePloS one2018
Devki Nandan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.